Odontogenic tumors consist of a heterogeneous group of lesions that originate from the tissue that forms the teeth ([@B1]). These tumors affect individuals in different age groups, involving mandibular and maxillary region, with central or peripheral location. Some lesions are asymptomatic and are discovered by chance through routine radiographs. Additionally, odontogenic tumors could promote the local expansion or facial swelling ([@B2], [@B3]). Pathogenesis of odontogenic tumors is not well known. Several studies were performed to identify genetic deregulations and molecular alterations in an attempt to explain the mechanisms of oncogenesis, cytodifferentiation, and tumor progression ([@B3], [@B4]).

Ameloblastoma (AM) is a benign tumor originating in the odontogenic epithelium without ectomesenchyme, affecting the maxillo-mandibular complex ([@B5]). It is an asymptomatic lesion, and it presents locally invasive behavior, and higher recurrence rates ([@B6]). The differential diagnosis includes a variety of odontogenic cysts and tumors, particularly keratocyst odontogenic tumor and myxoma, non-odontogenic tumors and cysts, as central giant cell lesions and fibro-osseous lesions ([@B7], [@B8]).

The keratocystic odontogenic tumor (KCOT), according to the most recent classification of tumors of the head and neck of the World Health Organization (WHO), has been categorized as benign neoplasm derived from odontogenic epithelium. The great clinical relevance of KCOT is related to aggressive clinical behavior, high recu-rrence and proliferation rate ([@B9], [@B10]). However, there are still disagreements, questioning whether this odontogenic lesion indeed is a neoplasm or a cyst of odontogenic nature ([@B11]). Some studies have sought to understand these aspects through mole-cular investigations ([@B11], [@B12]).

Despite efforts focused on understanding the pathogenesis of odontogenic tumors, little is known about the real influence of molecular pathways and gene deregulations in these tumors. Silico approaches, such as bioinformatic analysis, have been performed to investigate signaling pathways, protein interactions, microRNA prediction models, and gene expression to obtain the best understanding of pathological mechanisms of diseases ([@B13]). The computational method is an important tool to understand molecular aspects of oral pathology and medicine ([@B14]-[@B16]).

This study aimed to investigate the differential involvement of protein-coding genes in the pathogenesis of AM and KCOT, through bioinformatics analysis.

Materials and methods
=====================

**Bioinformatics and biological systems analysis**

Initially, key genes involved in the pathogenesis of AM and KCOT were identified by searching the GeneCards database ([@B17]). The gene nomenclature adopted was defined by Human Genome Organization (HUGO). The keywords, chosen according to Medical Subject Headings (MeSH), were "ameloblastoma and gene expression" and "keratocystic odontogenic tumor and gene expression".

After this step, a list of potential "candidate genes" related to AM and KCOT was generated to each tumor. Then, this gene list was expanded using the web-available software STRING (version 9.1) ([@B14]), mapping the interaction network between these protein-coding genes. Direct and indirect gene interactions were considered with a high degree of confidence (above 0.9, range 0-0.99) ([@B14])**.**With this process, new genes linked to AM and KCOT could be identified. For every gene interaction identified, we summed the interaction score of each gene, generating a combined association score. This score was adjusted, multiplying it by 1,000 ([@B14]), to obtain a single value called weighted number of links (WNL). The genes that showed the largest WNL values were named "leader genes" ([@B14]). Total interaction score (TIS) was also calculated using all interaction data generated by the STRING database to achieve global connectivity for each gene involved in the process ([@B14]). The value of WNL/TIS ratio represents the most influential genes in the network (specificity score). Genes with no link (orphan genes) were excluded from this analysis.

Genes were ranked according to this parameter in clusters, by the clustering method K-means. The number of clusters was calculated using the following equation: *Cluster number =TETO (LOG(CONT.NÚM(N);2);1)*. The number of clust-ers was obtained when mathematical convergence was achieved. To evaluate the differences among various classes based on WNL, Kruskal-Wallis test was used. Statistical significance was set at a p-value \<0.001. Interacting genes were classified as up-regulated or down-regulated, as previously described ([@B14]), to each type of odontogenic tumor, AM or KCOT. Complementary analysis of biological systems was performed by topological and ontological analysis. The first was carried out with Cytoscape software ([@B18]), and ontological analysis was performed with BinGO plugin ([@B14]).

**Literature review**

A literature review was performed according to inclusion and exclusion criteria of the Preferred Reporting Items for Systematic Reviews and methodology Meta-Analyses (PRISMA). Literature review data were used to corroborate the bioinformatics data. The main question was \"to verify genes that have been associated with AM or KCOT pathogenesis.\" The primary search was conducted in MEDLINE/PubMed database. The following keywords and their synonyms were used: \"ameloblastoma and gene expression\" and \"kera-tocystic odontogenic tumor and gene expression.\" "Gene expression" corresponds to each of the genes obtained from GeneCard and leader genes.

The initial survey of the articles was conducted by three researchers (coauthors) according to the following inclusion criteria: articles published in English, with availability in its full version, whose study has been conducted with laboratory experiments and that addressed the topic of interest. After the initial selection of material, items with incompatible content with the object of the study were excluded. The final research material was made up of 66 selected papers for AM and 25 for KCOT. The synthesis of the collected data and evidence analysis are based on information regarding the characteristics, methods and study endpoints (title, aim, methodological design, sample, results, conclusion and level of evidence).

Results
=======

**Survey of genes associated with AM and KCOT pathogenesis and interaction network**

The search through GeneCards and String database included 119 genes related to AM and 54 genes related to KCOT. [Figures 1a and 1b](#F1){ref-type="fig"} show gene interaction maps and also increased and decreased gene expression in AM and KCOT, respectively. This figure also reveals the orphan genes. In the gene interaction network for AM, genes were the following: *AIFM1*, *AMBN*, *AMELX*, *AMELY*, *BCL2L15*, *CADM1*, *CALB2*, *CD68*, *CHKA*, *CLDN4*, *CLDN5*, *DSPP*, *ENAM*, *HOTAIR*, *HOXC13*, *HSPD1*, *IBSP*, *KRT14*, *KRT19*, *KRT7*, *MME*, *MMP26*, *NCAM1*, *PDPN*, *PMS1*, *RHOA*, *RUNX2*, *SERPINA3*, *TDGF1*, *TMSB4X*. furthermore, orphan genes in the network for KCOT were *ALCAM*, *CALB2*, *CSF1*, *CSTB*, *CTNNBIP1*, *FHIT*, *G6PD*, *HPSE*, *KRT10*, *KRT13*, *KRT18*, *KRT19*, *KRT4*, *KRT6B*, *LELP1*, *MIR15A*, *MIR16-1*, *MMP26*, *MMP8*, *PDPN*, *PECAM1*, *PI3*, *SPP1*, *SPRR1A*, *SPRR3*.

Data analysis related to clustering and distribution of genes by cluster for AM and KOT diseases are represented in [Figure 2](#F2){ref-type="fig"}. [Figures 2a and 2c](#F2){ref-type="fig"} show the number of genes in the class of leader genes versus the increasing number of clusters; a preliminary k-means analysis revealed a cluster number equal to 7 for AM, and 6 for KCOT. Additionally, analysis points to the number of genes belonging to the leader cluster, being 1 for AM, and 2 for KCOT. [Figures 2b and 2d](#F2){ref-type="fig"} show the number of genes in each class, and also demonstrate leader genes for each tumor. The WNL for each gene in the data sets are displayed in [Figure 2](#F2){ref-type="fig"}. In AM, the highest WNL values were identified in genes *CDK1*, *CCND1*, *TP53*, *CDK2*, *AKT1*, *CCNA2*, *PCNA*, *CDKN1A*. Already, in KCOT, the most relevant WNL values were for *TP53*, *PCNA*, *BIRC5*, *CDK2*, *CCND1*, *CDKN1A*, *IL6*, *CDK4*, *VEGFA* genes. Clustering analysis of WNL identified only *CDK1* gene belonging to the largest cluster for AM. In the KCOT group, results show *PCNA* and *TP53* genes in the largest cluster.

![Gene interaction map and up- and down were regulated genes involved in ameloblastoma (a) and keratocyst odontogenic tumor (b). Data was derived from STRING (level of confidence \> 0.9). Down-regulation is a red bar and up-regulation is a green arrow. Yellow circle represents that the directionality of the interaction is known, but it is not known whether it results from the interaction (e.g., if it is up- or down regulated). Black circle at both ends means some kind of interaction between the two proteins, but the directionality is not known. In deep blue: binding; in blue: phenotype; in indigo blue: catalysis; in violet: post-translation; in black: reaction; and in yellow: expression](ijmcm-5-199-g001){#F1}

![Data analysis of clustering for ameloblastoma (a and b) and keratocyst odontogenic tumor (c and d). Genes belonging to the leader cluster in different k-means clustering experiments with an increasing number of clusters. In red: number of clusters used (a and c); Number of cases in clusters with WNL for genes involved in the phenomenon. In red: gene leader cluster (b and d](ijmcm-5-199-g002){#F2}

Results were validated using the Kruskal-Wallis test, which revealed a statistically significant difference in WNL. In particular, the statistic analysis showed that leader genes had a signifi-cantly greater WNL than other classes of genes (P\< 0.001). In this analysis, it was noted that both AM and KCOT tumors showed a power law behavior in agreement with the scale-free theory of network (In AM, correlation: 0.891; R^2^:0.855. In KCOT, corre-lation: 0.791; R^2^: 0.644)([Figure 3a and 3b](#F3){ref-type="fig"}). Power law distributions tend to differentiate nodes into specific points, meaning that some nodes have a tendency to have a low value, and consequently few number of connections, while other nodes, in turn, have a very high degree. In our case, we saw that few genes showed a large number of connections, whereas most of the genes showed few links. In this case, the high degree nodes are leader genes.

**Topological analysis**

A clustering coefficient was used to measure the degree of cohesion between the groups of genes. This numeric variable indicates the extent to which a gene is integrated into a given group. Clustering coefficient was close to zero (0.028) for AM, and zero for KCOT, demonstrating the importance of leader genes in connection between vertices and their neighbors ([Table 1](#T1){ref-type="table"}). When a gene appears above the regression line and very close to the Y axis, it means that it has a high specificity (WNL) and less global connectivity (TIS) suggesting that it is a leader gene. [Figure 4a](#F4){ref-type="fig"} and 4b show the disease- related connectivities (WNL) versus the global connectivities (TIS). The WNL/TIS ratio indicated that the leader genes from AM (CDK) and KCOT (*PCNA* and *TP53*) were influential genes in the interaction networks.

![Power law behavior. a: ameloblastoma; b: keratocystic odontogenic tumor](ijmcm-5-199-g003){#F3}

###### 

Global topological analysis for Ameloblastoma and Keratocystic odontogenic tumor network

  **Parameter**                        **Value**      **Parameter**           **Value**
  ------------------------------------ -------------- ----------------------- -----------
  **Ameloblastoma**                                                           
  Clustering coefficient               0.028          Number of nodes         150
  Connected components                 1              Network density         0.021
  Network diameter                     13             Network heterogeneity   0.510
  Network radius                       7              Isolated nodes          0
  Network centralization               0.053          Number of self-loops    0
  Shortest paths                       13574 (100%)   Multi-edge node pairs   0
  Characteristic path length           5.924          Analysis time (sec)     0.250
  Avg. number of neighbors             3.187          \-                      \-
  **Keratocystic odontogenic tumor**                                          
  Clustering coefficient               0.0            Number of nodes         34
  Connected components                 1              Network density         0.087
  Network diameter                     12             Network heterogeneity   0.355
  Network radius                       6              Isolated nodes          0
  Network centralization               0.100          Number of self-loops    0
  Shortest paths                       1122 (100%)    Multi-edge node pairs   0
  Characteristic path length           4.750          Analysis time (sec)     0.035
  Avg. number of neighbors             2.882          \-                      \-

![Scatter diagrams showing disease-related connectivities (WNL: weighted number of links) versus the global connectivities (TIS: total interactions score). a: ameloblastoma; b: keratocystic odontogenic tumor](ijmcm-5-199-g004){#F4}

**Ontological analysis**

The ontology for both AM and KCOT demonstrated different mechanisms associated to AM and KCOT ([Figure 5a and 5b](#F5){ref-type="fig"} , respectively). In AM, aspects such as cell cycle process, regulation of cell cycle, regulation of mitotic cell cycle, interphase of mitotic cell cycle were relevant. In KCOT, regulation of DNA metabolic processes, mitotic cell cycle regulation, cell cycle regulation, as well as cellular response to a stimulus, cellular response to stress, and response to DNA damage were relevant. The mechanism of cell cycle regulation, for both AM and KCOT, was observed to be an outcome measure along with proliferation and anti-apoptotic mechanisms.

**Literature review**

Studies have demonstrated several genes related to AM and KCOT, but in literature, many controversies exist over whether it is involved in disease progression or, conversely, in tumor inhibition. So, we performed a short overview of literature regarding potentially involved genes and their expression in the pathogenesis of AM and KCOT. Expression levels (increase or decrease) of different genes were identified in this study, for both AM and KCOT, as summarized in [Table 2](#T2){ref-type="table"}.

###### 

Gene expression in Ameloblastoma and Keratocystic odontogenic tumor according to the literature review.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Gene** **symbol**                  **Level**                                                                                                                                   **In comparison of**                                                                                                                         **Methodology**                                                                                         **Ref.**
  ------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- ----------
  **AMELOBLASTOMA**                                                                                                                                                                                                                                                                                                                                                                                                                     

  CDK1                                 Expression of CDK1,-4, and - 6 was not changed, even with the induced overexpression of AMBN.                                               Primary dental epithelium bound to full-length AMBN                                                                                          PCR and Western Blotting                                                                                \(19\)

  CCND1                                Increase                                                                                                                                    Keratocyts                                                                                                                                   Immunohistochemistry                                                                                    \(20\)

  TP53                                 Increase                                                                                                                                    Adenomatoid odontogenic tumor                                                                                                                *Immunohistochemistry*                                                                                  \(21\)

  CDK2                                 Overexpressed                                                                                                                               Dentigerous cyst                                                                                                                             Microarray analysis, RT-PCR, and immunohistochemistry                                                   \(22\)

                                       No changed                                                                                                                                  No control group                                                                                                                             Microarrays and immunohistochemistry                                                                    \(23\)

  AKT1                                 Decrease                                                                                                                                    Under treatment of TNFα                                                                                                                      Western blot/ Apoptosis assay/ DAPI staining                                                            \(24\)

                                       Increase                                                                                                                                    Ameloblastoma tissues                                                                                                                        **Immunohistochemistry/ Immunoblotting/Immunofluorescence/ELISA**                                       \(21\)

  PCNA                                 Increased                                                                                                                                   Odontogenic keratocyst                                                                                                                       Immunohistochemistry                                                                                    \(25\)

  CDK4                                 Increase                                                                                                                                    Rodent dental epithelial cell lines                                                                                                          Immunofluorescence/ immunohistochemistry                                                                \(26\)

  RB1                                  Increase                                                                                                                                    Cystic odontogenic tumor (CCOT)                                                                                                              PCR                                                                                                     \(27\)

  JUN                                  Increase                                                                                                                                    Normal oral mucosa                                                                                                                           *In situ* hybridization                                                                                 \(28\)

  CTNNB1                               Increase                                                                                                                                    Oral basal cell carcinoma                                                                                                                    Immunohistochemistry                                                                                    \(29\)

  NOTCH1                               Decrease                                                                                                                                    Tooth germ                                                                                                                                   **Immunohistochemistry/ PCR Real Time**                                                                 \(30\)

                                       High                                                                                                                                        No comparison                                                                                                                                Immunohistochemistry                                                                                    \(31\)

  MTOR                                 Increase                                                                                                                                    Dentigerous cysts (DCs), odontogenic keratocysts (OKCs)                                                                                      Immunohistochemistry                                                                                    \(32\)

  EGFR                                 No expression                                                                                                                               Normal oral mucosa                                                                                                                           Immunohistochemistry                                                                                    \(33\)

                                       Increase                                                                                                                                    Inflammatory cyst                                                                                                                            Immunohistochemistry                                                                                    \(34\)

  E2F1                                 High                                                                                                                                        None                                                                                                                                         Immunohistochemistry                                                                                    \(35\)

                                       Increase                                                                                                                                    Tooth germs                                                                                                                                  Immunohistochemistry                                                                                    \(36\)

  FOS                                  Increased                                                                                                                                   Other genes                                                                                                                                  Real-time PCR                                                                                           \(12\)

  MDM2                                 Increased                                                                                                                                   ***Adenomatoid odontogenic tumor***                                                                                                          Immunohistochemistry                                                                                    \(37\)

  RAC1                                 No expression                                                                                                                               None                                                                                                                                         Immunohistochemistry                                                                                    \(38\)

  PTEN                                 Decrease                                                                                                                                    Tooth germs                                                                                                                                  Immunohistochemistry                                                                                    \(39\)

  MMP9                                 Strongly expressed in mural, moderately in intraluminal, and weakly to absent in luminal variant                                            None                                                                                                                                         Immunohistochemistry                                                                                    \(40\)

  MMP2                                 Increased                                                                                                                                   Odontotheca tissues                                                                                                                          Real-time PCR                                                                                           \(41\)

  MMP1                                 High                                                                                                                                        None                                                                                                                                         Immunohistochemistry                                                                                    \(42\)

  CDC42                                No difference                                                                                                                               Follicular and plexiform ameloblastomas                                                                                                      **Immunohistochemistry**                                                                                \(38\)

  RUNX2                                Low                                                                                                                                         None                                                                                                                                         PCR/ Western Blot/ Immunohistochemical                                                                  \(43\)

  PTCH1                                Same (High)                                                                                                                                 keratocystic odontogenic tumors                                                                                                              Immunohistochemistry.                                                                                   \(44\)

  BMP4                                 Expressed                                                                                                                                   None                                                                                                                                         Real- time PCR                                                                                          \(45\)

  MMP14                                Higher in recurrent and solid/ multicystic ameloblastoma\                                                                                   No control group                                                                                                                             **PCR**                                                                                                 \(41\)
                                       tissues than in primary and unicystic ameloblastoma tissues respectively                                                                                                                                                                                                                                                                                                                         

  BCL2                                 High                                                                                                                                        P21                                                                                                                                          Immunohistochemistry                                                                                    \(46\)

  TIMP2                                Low                                                                                                                                         Dentigerous cysts (DCs), radicular cysts (RCs), keratocystic odontogenic tumors (KOTs),                                                      Immunohistochemistry                                                                                    \(47\)

  NOTCH2                               No expression                                                                                                                               Solid/multicystic (SA) and unicystic ameloblastomas (UA) recurrent ameloblastoma                                                             Immunohistochemistry                                                                                    \(48\)

  TERT                                 Decreased                                                                                                                                   Oral mucosa                                                                                                                                  RT-PCR                                                                                                  \(49\)

  CASP9                                Same                                                                                                                                        Tooth germs                                                                                                                                  RT PCR                                                                                                  \(50\)

  APC                                  Low                                                                                                                                         Tooth germs                                                                                                                                  Immunohistochemistry                                                                                    \(51\)

  VIM                                  Expressed                                                                                                                                   None                                                                                                                                         Immunohistochemistry                                                                                    \(52\)

  SHH                                  Low expression                                                                                                                              Keratocystic Odontogenic tumor/ ameloblastoma                                                                                                **Immunohistochemistry**                                                                                \(44\)

  MKI67                                Low                                                                                                                                         PCNA                                                                                                                                         Immunohistochemistry                                                                                    \(53\)

  TNFRSF1A                             Increased                                                                                                                                   Tooth germ                                                                                                                                   RT PCR                                                                                                  \(12\)

  MSX2                                 Decreased                                                                                                                                   P21 e p27                                                                                                                                    RT PCR Western blot                                                                                     \(53\)

  TNFSF11                              Increased                                                                                                                                   Radicular cysts (RCs), dentigerous cysts (DCs)                                                                                               Immunohistochemistry                                                                                    \(54\)

  APAF1                                Same                                                                                                                                        Toothe germs                                                                                                                                 Immunohistochemical                                                                                     \(50\)

  SMO                                  Same (High)                                                                                                                                 keratocystic odontogenic tumors (KOT)                                                                                                        Immunohistochemistry                                                                                    \(44\)

  RECK                                 Low or no expression                                                                                                                        keratocystic odontogenic tumor                                                                                                               Immunohistochemistry and RT-PCR                                                                         \(55\)

  TNFRSF11B                            Expressed                                                                                                                                   None                                                                                                                                         Immuhistochemistry, immunofluorescence and Western blot                                                 \(56\)

                                       Lower                                                                                                                                       Tooth germs                                                                                                                                  RT-PCR and Immunohistochemistry                                                                         \(57\)

  GLI1                                 High                                                                                                                                        Epithelial cells than in mesenchymal cells                                                                                                   RT-PCR and Immunohistochemistry                                                                         \(58\)

  TRAF3                                Low expression                                                                                                                              Tooth germ                                                                                                                                   cDNA microarray and real-time RT-PCR                                                                    \(12\)

  TNFRSF10B                            Diffusely expressed                                                                                                                         None                                                                                                                                         **Immunohistochemistry**                                                                                \(59\)

  KRT18                                Weakly and diffusely expressed                                                                                                              Tumor cells                                                                                                                                  Immunohistochemistry                                                                                    \(60\)

  KRT8                                 No expression.                                                                                                                              None                                                                                                                                         **Immunohistochemistry**                                                                                \(61\)

  TNFRSF10A                            Diffusely expressed                                                                                                                         None                                                                                                                                         Immunohistochemistry                                                                                    \(59\)

  TNFRSF11A                            Expressed                                                                                                                                   Plexiform ameloblastomas than in follicular ameloblastomas                                                                                   RT-PCR and Immunohistochemistry                                                                         \(57\)

  NOS2                                 Increased                                                                                                                                   Tooth germs                                                                                                                                  Immunohistochemistry                                                                                    \(62\)

  WNT1                                 High                                                                                                                                        None                                                                                                                                         Immunohistochemistry                                                                                    \(63\)

  WNT5A                                High                                                                                                                                        None                                                                                                                                         Immunohistochemistry                                                                                    \(64\)

  MAP2K1                               Expressed                                                                                                                                   None                                                                                                                                         Immunohistochemistry                                                                                    \(65\)

  TNFRSF10C                            Diffusely expressed                                                                                                                         None                                                                                                                                         Immunohistochemistry and an in situ DNA nick-end labeling method                                        \(59\)

  PDGFRA                               Regularly expressed                                                                                                                         None                                                                                                                                         Immunohistochemistry                                                                                    \(66\)

  SFRP2                                Strongly                                                                                                                                    None                                                                                                                                         Immunohistochemistry and western blot                                                                   \(67\)

  TP63                                 Higher                                                                                                                                      Plexiform ameloblastomas than in follicular ameloblastomas                                                                                   Immunohistochemistry and RT-PCR                                                                         \(68\)

  MMP20                                No expression                                                                                                                               None                                                                                                                                         Immunohistochemistry                                                                                    \(69\)

  PDGFA                                High                                                                                                                                        Follicular ameloblastomas than in plexiform ameloblastomas                                                                                   Immunohistochemistry                                                                                    \(70\)

                                       Regularly expressed                                                                                                                         None                                                                                                                                         Immunohistochemistry                                                                                    \(66\)

  SPARC                                High                                                                                                                                        None                                                                                                                                         **Immunohistochemistry**                                                                                \(71\)

  RHOB                                 High                                                                                                                                        Solid ameloblastoma.                                                                                                                         Immunohistochemistry                                                                                    \(38\)

  WNT2                                 No expression or low                                                                                                                        None                                                                                                                                         **Immunohistochemistry**                                                                                \(63\)

  **KERATOCYSTIC ODONTOGENIC TUMOR**                                                                                                                                                                                                                                                                                                                                                                                                    

  TP53                                 Low                                                                                                                                         Peripheral odontogenic keratocyst                                                                                                            Immunohistochemistry                                                                                    \(72\)

  PCNA                                 Highest level was in the suprabasal layer of KCOT                                                                                           Radicular cysts, dentigerous cysts, and calcifying cystic odontogenic tumors                                                                 Immunohistochemistry                                                                                    \(73\)

  CCND1                                Overexpression of downstream                                                                                                                Non-neoplastic oral mucosa                                                                                                                   qPCR and immunohistochemistry                                                                           \(44\)

  IL6                                  Higher expression rates were associated with tumor size in ameloblastomas and with cyst wall thickness in keratocystic odontogenic tumors   Cases of ameloblastomas and cases of orthokeratinized odontogenic keratocysts                                                                Immunohistochemistry                                                                                    \(74\)

  VEGFA                                High                                                                                                                                        Primary ameloblastoma, recurrent ameloblastoma, and malignant ameloblastoma                                                                  Immunohistochemical                                                                                     \(75\)

  ALCAM                                Deletion                                                                                                                                    No control group                                                                                                                             Immunohistochemistry, Array-comparative Genomic Hybridization Labeling, qRT-PCR                         \(76\)

  BCL2                                 Higher expression                                                                                                                           KCOT and dental follicles                                                                                                                    Immunohistochemistry,RNA isolation and quantitative reverse transcription (qRT-PCR) ,Western blotting   \(77\)

  CALB2                                Expression less                                                                                                                             KCOT and ameloblastoma                                                                                                                       Immunohistochemistry                                                                                    \(78\)

  CASP3                                Express                                                                                                                                     KCOT, Ameloblastoma cisto radicular                                                                                                          immunohistochemical                                                                                     \(79\)

  FGFR2                                Express                                                                                                                                     OKC, dentigerous cyst, glandular odontogenic cyst, gingival cyst of the adult and the radicular cyst exhibited and normal dental follicles   Western blot analysis and immunohistochemistry                                                          \(80\)

  FHIT                                 High                                                                                                                                        Dentigerous cysts (DC) and radicular cysts (RC)                                                                                              Immunohistochemistry                                                                                    \(81\)

  GLI1                                 Overexpression                                                                                                                              None                                                                                                                                         Immunohistochemistry                                                                                    \(82\)

  GLI2                                 Overexpression                                                                                                                              None                                                                                                                                         Immunohistochemistry                                                                                    \(82\)

  KRT6B                                Over-expressed in 12q13                                                                                                                     Tooth germs                                                                                                                                  Immunohistochemistry                                                                                    \(76\)

  MKI67                                Significantly higher                                                                                                                        The cell proliferation and p53 protein expression (KCOT)                                                                                     Immunohistochemistry                                                                                    \(83\)

  MMP13                                Positive labelling                                                                                                                          Non-nevoid basal cell                                                                                                                        Immunohistochemistry                                                                                    \(84\)

  MMP9                                 Predominance                                                                                                                                Follicular cyst                                                                                                                              Immunohistochemistry                                                                                    \(85\)

  PTCH1                                Frequently detected genetic and/or epigenetic mechanisms of inactivation of the PTCH1 in KCOT                                               Genetic and/or epigenetic mechanisms of inactivation of the PTCH1 in KCOT                                                                    PTCH1 mRNA expression and methylation                                                                   \(86\)

  PTCH2                                Germline mutations were detectable                                                                                                          Keratocystic odontogenic tumors                                                                                                              PCR-direct sequencing                                                                                   \(87\)

  SHH                                  Expressed                                                                                                                                   None                                                                                                                                         Immunohistochemical                                                                                     \(88\)

  SMO                                  No pathogenic mutation                                                                                                                      NBCCS-associated KCOTs                                                                                                                       Mutational analysis                                                                                     \(89\)

  SPP1                                 Expressed                                                                                                                                   None                                                                                                                                         Immunohistochemistry                                                                                    \(90\)

  TNFRSF11B                            High                                                                                                                                        Solid ameloblastomas (SAs),                                                                                                                  Immunohistochemistry using anti-RANKL and anti-OPG antibodies                                           \(54\)

  TNFSF11                              High                                                                                                                                        Dentigerous cysts (DCs), solid ameloblastomas (SAs)                                                                                          Immunohistochemistry using anti-RANKL and anti-OPG antibodies                                           \(54\)

  TP63                                 Higher                                                                                                                                      Epithelial lining of radicular cysts (RC), dentigerous cysts (DC)                                                                            Immunohistochemical                                                                                     \(75\)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

![Ontology analysis of ameloblastoma (a) and Keratocystic odontogenic tumor (b) network. The most important pathways overrepresented in the graph versus whole set annotation, carried out with BinGO software (P \< 0.01, Benjamini-Hochberg correction,hypergeometric clustering) are shown](ijmcm-5-199-g005){#F5}

Discussion
==========

AM and KCOT are odontogenic tumors strongly associated with cell proliferation and apoptosis inhibition ([@B91],[@B92]). Literature reports have shown that an increase in the expression of caspase-3 and MMP-2 proteins are associated with growth and progression of KCOT and AM, indicating possible mechanisms involved in the recurrence KCOT and AM invasion. Moreover, epithelial lining of KCOTs showed a high turnover of cells suggesting that KCOT lesion can present neoplastic potential, as AM ([@B79]). Hence, studies have focused on molecular marker investigations for a better understanding of KCOT and AM pathogenesis.

In this sense, this study is the first to show, through bioinformatics analysis, interaction networks between protein- coding genes, leader genes and molecular pathways that can be related to the pathogenesis of AM and KCOT. Leader genes identified in the current study show distinct profiles between the odontogenic tumors; *CDK1* being the leader gene in AM, and *TP53* and *PCNA* as the leader genes in KCOT. All of these genes are somehow involved in apoptosis, cell cycle regulation, and cell proliferation.

The etiology and pathogenesis of AM are still not well understood. However, several factors such as *SHH*, *WNT*, *NOTCH*, *AKT* and *FGF* can be responsible for AM aggressiveness ([@B93]). In this context, it appears that both AM and KCOT are consequences of cell cycle deregulation, and/or apoptosis inhibition. The function of leader genes identified in this study coincides with the high proliferative activity of odontogenic epithelium in AM and KCOT. The literature reported a higher cell proliferation in KCOT than AM and similar apoptosis index between these tumors ([@B94]). These findings can support the classification of KCOT as an odontogenic tumor and can be related to its aggressive clinical behavior ([@B94]). Similarly, another study showed the aggressive nature of KCOT. KCOT and AM have been clearly demonstrated to have both intrinsic growth potential and aggressive invasive behavior ([@B95]).

Interestingly, no study was found in the literature aiming to evaluate specifically the role of *CDK1* gene, identified by our bioinformatics analysis as a leader gene in AM. Our literature search revealed a single study where *CDK1*expression was reported in human ameloblastoma AM-1 cells ([@B19]). The expression of *CDK1*, *-4*, and *-6* was not changed in AM-1 cells, even with the induced overexpression of ameloblastin gene that may function as a tumor suppressor. Therefore, the *CDKs* remained expressed in the AM-1 cells ([@B19]). The CDK1-cyclin B complex is essential to initiate mitosis and can phosphorylate a wide range of proteins involved in regulatory and structural processes necessary for mitosis such as the nuclear envelope breakdown, condensation of chromatin, fragmentation of the golgi apparatus, and training of mitotic spindles ([@B96]).

Other studies have evaluated gene expression of other cyclin-dependent kinases and their receptors. Cyclin D1 was expressed in epithelial cells near the basement membrane in dental germs and AM. This fact seems to indicate that this protein is involved in cell proliferation in odontogenic epithelium and ameloblastic tumors ([@B97], [@B98]). The mRNA expression of cyclin E increased with AM recurrence and malignant transformation suggesting that genesis and invasion of AM are associated with the cell proliferation and differentiation, and are well-regulated by the increased expression of cyclin E and the lower expression of p21(*WAF1*) and p27(*KIP1*) ([@B99]).

Despite the scarcity of studies on *CDK1* in AM, this gene was appointed as a leader gene due to the increased number of interaction networks that it establishes with other genes, especially related to increased activity of cell proliferation, as demonstrated in the analysis of clustering and ontology. In addition to leader genes, the bioinformatic analysis shows several genes possibly related to this tumor, such as *TP53*, *AKT1*, *PCNA*, *PTCH*, *mTOR, MMPs*, *BCL2* as well as others. By bioinformatics data, our literature review indicated that hedgehog signaling genes such as *HH*, *PTCH1*, *SMO*, and *GLI* are involved in AM pathogenesis. A high expression of SHH, SMO and GLI protein was reported in AM (4). Hedgehog (HH) signaling is a conserved pathway that guides embryonic patter-ning through the temporal and spatial regulation of cellular proliferation and differentiation ([@B100]). The HH pathway contributes to iASPP (inhibitor of the apoptosis-stimulating protein of p53) function, through the activation of Cyclin B1 and by the E2F1-dependent regulation of *CDK1*. These mecha-nisms are involved in iASPP induction. Results showed that activation of HH signaling enhances proliferation in the presence of E2F1 and contri-butes to apoptosis in its absence or upon CDK1 inhibition ([@B101]). In this bioinformatics study, the *CDK1* gene was considered as the leader of the molecular pathway of AM pathogenesis, demons-trating the importance of genes of the HH pathway in the pathogenesis of AM through the leader gene.

*TP53* and *PCNA*were identified as KCOT leader genes. Immunohistochemical studies have examined KCOT by using various markers of proliferation and apoptosis ([@B102], [@B103]). Proliferative activity of the epithelial lining of KCOT has been the subject of various investigations examining p53 expression ([@B102])[,]{.ul} proliferating cell nuclear antigen (PCNA) ([@B103]) and Ki-67 ([@B104]). These studies concluded that KCOT displays a greater expression of p53, PCNA, and Ki-67 as compared to other types of odontogenic cysts ([@B105]).

The first leader gene in KCOT was the *TP53*, which is consistent with the available scientific information about its role in tumor development ([@B106]). *TP53* is a tumor suppressor gene with effective action at the G1 phase of the cell cycle, which participates in growth arrest, initiates repair, or induces apoptosis ([@B107]). Immunodetection of this protein seems to influence the stabilization of the p53 product, an action which interferes with cell cycle regulation for proliferation ([@B108]), indicating an intrinsic growth potential of the KCOT epithelium ([@B109]). On the other hand, the literature review revealed weak expression of p53 in odontogenic lesions, such as KCOT and peripheral odontogenic keratocyst, in the same way as normal gingiva ([@B9]).

The second leader gene in KCOT was *PCNA*, encoding a nuclear protein linked to DNA replication and initiation of cell proliferation. Increased expression of PCNA may be stimulated with growth factors or as a result of DNA injury ([@B110]).

Molecular expression of p53 and PCNA in different odontogenic lesions revealed the highest level of both proteins in the suprabasal layer of KCOT compared with radicular cyst, dentigerous cyst, and Gorlin cyst, suggesting that proliferation and maturation patterns in KCOT differ from those found in the other lesions ([@B9]). Overexpression of *PCNA* in the suprabasal layer of the KCOT can clarify its neoplastic nature and a tendency toward tumor recurrence ([@B73]).

Similar to the AM, results revealed *PTCH* as a gene importantly involved in interaction network in KCOT. Previous studies showed evidence of mutations in the *PTCH* gene ([@B89], [@B111]), a tumor suppressor associated with nevoid basal cell carcinoma syndrome. Mutations in this gene could be responsible for migration and differentiation of abnormal cells, and also might interfere with apoptosis, which would lead to a deregulation of cell proliferation ([@B112]). Nonetheless, this gene was not designated as one of the leaders in our bioinformatics analysis, but it was highlighted by relevance described in the literature in both KCOT and AM ([@B113], [@B114]).

The analysis of interaction map allowed the identification of different groups of genes acting on cell cycle regulation in AM and KCOT. This search confirmed that each gene identified as a leader gene could supposedly play an important role in AM and KCOT. Nevertheless, literature survey also revealed that other genes might be potentially involved in the pathogenesis of AM and KCOT, as shown in [Table 2](#T2){ref-type="table"}.

In our bioinformatics analysis, the interaction network of leader genes with a significant number of genes of the apoptosis pathway suggests that cell cycle deregulation is an important molecular event in both AM and KCOT. Moreover, functional enrichments in our network obtained from STRING database showed that orphan genes not linked to leader genes are ontologically related to the cell adhesion molecules and structural molecule activity.

Bioinformatics conducts a theoretical analysis using public databases, gene database, and scientific publishing databases, to generate relevant information and new knowledge. These theoretical results are well-supported by findings in the literature on the contribution of genes to the pathogenesis of AM and KCOT. Thus, based on the bioinformatics results and literature survey, further laboratory experiments should be conducted to better explain the real importance of interaction networks between genes in the pathogenesis of odontogenic tumors.

These data obtained through bioinformatics analysis can contribute to an improved body of knowledge about genes and molecular mechanisms involved in AM and KCOT pathogenesis. It is noteworthy that a detailed analysis of gene interaction networks and molecular pathways can be of great value in identifying new targets for an understanding of diseases and also to point to possible therapeutic targets. In addition, bioinformatics analysis can be an important tool for designing a hypothesis before conducting functional studies.

In this study, some genes with an important potential role in the pathogenesis of AM and KCOT were identified. Even with the limitations of any theoretical study, these preliminary results may suggest the involvement of promising genes for a better understanding of these odontogenic tumors.
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